A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer
Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to determine whether the combination of 5-fluorouracil
(5-FU) plus a DAVANAT (carbohydrate polymer) along with Avastin and Leucovorin (LV) is
beneficial in treating colorectal cancer in patients unable to tolerate intensive
chemotherapy.